Arkin receives Ono Pharma Foundation Breakthrough Science Initiative Award
Michelle Arkin, PhD, has received the 2018 Breakthrough Science Initiative Award from theOno Pharma Foundation to study a class of proteins, called 14-3-3 proteins, known to be involved in various cancers, with the ultimate goal of enabling discoveries that lead to new ways to treat cancer.
Source: UCSF School of Pharmacy News - Category: Universities & Medical Training Authors: Levi Gadye Source Type: news
More News: Cancer | Cancer & Oncology | Pharmaceuticals | Science | Study | Universities & Medical Training